Inflammatory bowel disease in children: current trends.
Once considered rare in the East, inflammatory bowel disease (IBD) is now recognized to be an emerging entity in that region. East or West, the clinical features of and treatment options for IBD are the same, but it is possible that the exact pathogeneses or the initiating events differ. In this review, existing knowledge of IBD and new discoveries in the epidemiology, genetics and treatment of IBD are discussed in detail. The diagnosis and management of IBD in children has changed dramatically over the last decade, mainly due to increased awareness, the availability of newer diagnostic modalities such as MRI and video capsule endoscopy, and newer, more powerful treatments such as biologics. It is hoped that the combination of innovative research and advances in drug discoveries will change the natural history of IBD and make a major difference in children who are suffering from this unfortunate lifelong chronic inflammatory disorder.
Shikhare
Gargi
G
Division of Pediatric Gastroenterology, Department of Pediatrics and Human Genetics, Emory Children's Center, Emory University School of Medicine, 2015, Uppergate Drive, Room 248, Atlanta, GA, 30322, USA.
Kugathasan
Subra
S
D053704:Capsule Endoscopy / Q000379:methods; D002648:Child; D015195:Drug Design; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D008279:Magnetic Resonance Imaging / Q000379:methods; D012107:Research Design